tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OCGN Stock Latest News

OCGN Earnings: Ocugen’s Q3 Results Disappoint
Market NewsOCGN Earnings: Ocugen’s Q3 Results Disappoint
6m ago
OCGN
Options Volatility and Implied Earnings Moves Today, November 08, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, November 08, 2024
2h ago
TU
BAX
Ocugen reports Q3 revenue $1.136M, consensus $300,000
PremiumThe Fly
Ocugen reports Q3 revenue $1.136M, consensus $300,000
2h ago
OCGN
OCGN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
OCGN Earnings this Week: How Will it Perform?
2d ago
OCGN
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
8d ago
API
VFS
Ocugen announces DSMB for OCU410ST trial approved enrollment for second phase
PremiumThe FlyOcugen announces DSMB for OCU410ST trial approved enrollment for second phase
17d ago
OCGN
Etsy, Enphase downgraded: Wall Street’s top analyst calls
Premium
The Fly
Etsy, Enphase downgraded: Wall Street’s top analyst calls
24d ago
BX
CEG
Maxim starts Ocugen at Buy on large addressable market sizes
Premium
The Fly
Maxim starts Ocugen at Buy on large addressable market sizes
24d ago
OCGN
Ocugen initiated with a Buy at Maxim
PremiumThe Fly
Ocugen initiated with a Buy at Maxim
24d ago
OCGN
Ocugen Advances Promising Pipeline Amid Financial Restraints
PremiumMarket News
Ocugen Advances Promising Pipeline Amid Financial Restraints
25d ago
OCGN
Ocugen: FDA lifts clinical hold on IND application for OCU200 Phase 1 trial
PremiumThe Fly
Ocugen: FDA lifts clinical hold on IND application for OCU200 Phase 1 trial
1M ago
OCGN
Ocugen’s (OCGN) Stock Has Surged 195% on Promising Gene Therapy Treatment
PremiumMarket News
Ocugen’s (OCGN) Stock Has Surged 195% on Promising Gene Therapy Treatment
2M ago
OCGN
Ocugen completes dosing in Phase 1/2 trial of Stargardt disease candidate
PremiumThe FlyOcugen completes dosing in Phase 1/2 trial of Stargardt disease candidate
2M ago
OCGN
Ocugen announces Health Canada sent “No Objection Letter” for OCU400 trial
Premium
The Fly
Ocugen announces Health Canada sent “No Objection Letter” for OCU400 trial
2M ago
OCGN
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
ENB
ANVS
Ocugen reports Q2 EPS (4c), consensus (5c)
PremiumThe Fly
Ocugen reports Q2 EPS (4c), consensus (5c)
3M ago
OCGN
Ocugen receives FDA approval for EAP for patients with retinitis pigmentosa
PremiumThe Fly
Ocugen receives FDA approval for EAP for patients with retinitis pigmentosa
3M ago
OCGN
Ocugen 30.4M share Spot Secondary priced at $1.15
PremiumThe Fly
Ocugen 30.4M share Spot Secondary priced at $1.15
3M ago
OCGN
Ocugen announces common stock offering, no amount given
PremiumThe Fly
Ocugen announces common stock offering, no amount given
3M ago
OCGN
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
3M ago
UL
UP
Ocugen completes dosing in Phase 1/2 trial of OCU410 in geographic atrophy
Premium
The Fly
Ocugen completes dosing in Phase 1/2 trial of OCU410 in geographic atrophy
4M ago
OCGN
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
UP
UCO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >